FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2090311000001103: Cabaser 2mg tablets (Pfizer Ltd) 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25078701000001112 Cabaser 2mg tablets (Pfizer Ltd) 20 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25078801000001115 Cabaser 2mg tablets (Pfizer Ltd) 20 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Is a Cabergoline 2mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Is pack of Cabaser 2mg tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has AMP Cabaser 2mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabaser 2mg tablets (Pfizer Ltd) 20 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start